Ursula Matulonis, MD Shares Results of the SORAYA Study
Dana-Farber
March 30, 2022
Ursula Matulonis, MD presented results of the SORAYA study at the 2022 Society for Gynecologic Oncology Annual Meeting. The study examined the efficacy and safety of mirvetuximab soravtansine in patients with platinum-resistant ovarian cancer with high folate receptor alpha expression.